Back to Agenda
Module 6: Phase 4 and Lifecycle Management
Session Chair(s)
Stephen V. O'Quinn, PharmD
President
Perissos, Inc., United States
- Product Lifecycle
- Product Enhancement
- Phase 4 Studies
- New Indications
- New Dosage Forms
Have an account?
Already a DIA Member? Sign in. Not a member? Join.
Sign in
Not a Member?
Seaport Hotel
Aug 12, 2019 2:00 PM - Aug 13, 2019 10:15 PM
One Seaport Lane, Boston, MA 02210
New Drug Product Development and Lifecycle Management
Gain a better understanding of how companies structure efforts to improve the odds of successful development and minimize risks associated with shepherding a new drug candidate through the process.